AAAAAA
Results:
1-12
|
Results: 12
Authors:
Langer, O
Dolle, F
Valette, H
Halldin, C
Vaufrey, F
Fuseau, C
Coulon, C
Ottaviani, M
Nagren, K
Bottlaender, M
Maziere, B
Crouzel, C
Citation: O. Langer et al., Synthesis of high-specific-radioactivity 4- and 6-[F-18]fluorometaraminol-PET tracers for the adrenergic nervous system of the heart, BIO MED CH, 9(3), 2001, pp. 677-694
Authors:
Dolle, F
Valette, H
Hinnen, F
Demphel, S
Bramoulle, Y
Peglion, JL
Crouzel, C
Citation: F. Dolle et al., Highly efficient synthesis of [C-11]S12968 and [C-11]S12967, for the in vivo imaging of the cardiac calcium channels using PET, J LABEL C R, 44(7), 2001, pp. 481-499
Authors:
Dolle, F
Hinnen, F
Vaufrey, F
Demphel, S
Bramoulle, Y
Fournier, D
Ponchant, M
Valette, H
Crouzel, C
Citation: F. Dolle et al., Highly efficient synthesis of [C-11]Me-QNB, a selective radioligand for the quantification of the cardiac muscarinic receptors using PET, J LABEL C R, 44(5), 2001, pp. 337-345
Authors:
Dolle, F
Valette, H
Hinnen, F
Vaufrey, F
Demphel, S
Coulon, C
Ottaviani, M
Bottlaender, M
Crouzel, C
Citation: F. Dolle et al., Synthesis and preliminary evaluation of a carbon-11-labelled agonist of the alpha 7 nicotinic acetylcholine receptor, J LABEL C R, 44(11), 2001, pp. 785-795
Authors:
Valette, H
Dolle, F
Guenther, I
Hinnen, F
Fuseau, C
Coulon, C
Peglion, JL
Crouzel, C
Citation: H. Valette et al., Myocardial kinetics of the C-11-labeled enantiomers of the Ca2+ channel inhibitor S11568: An in vivo study, J NUCL MED, 42(6), 2001, pp. 932-937
Authors:
Langer, O
Valette, H
Dolle, F
Halldin, C
Loc'h, C
Fuseau, C
Coulon, C
Ottaviani, M
Bottlaender, M
Maziere, B
Crouzel, C
Citation: O. Langer et al., High specific radioactivity (1R,2S)-4-[F-18]fluorometaraminol: A PET radiotracer for mapping sympathetic nerves of the heart, NUCL MED BI, 27(3), 2000, pp. 233-238
Authors:
Dolle, F
Bottlaender, M
Demphel, S
Emond, P
Fuseau, C
Coulon, C
Ottaviani, M
Valette, H
Loc'h, C
Halldin, C
Mauclaire, L
Guilloteau, D
Maziere, B
Crouzel, C
Citation: F. Dolle et al., Highly efficient synthesis of [C-11]PE2I, a selective radioligand for the quantification of the dopamine transporter using PET, J LABEL C R, 43(10), 2000, pp. 997-1004
Authors:
Valette, H
Dolle, F
Guenther, I
Demphel, S
Rasetti, C
Hinnen, F
Fuseau, C
Crouzel, C
Citation: H. Valette et al., Preliminary evaluation of 2-[4-[3-(tert-butylamino)-2-hydroxypropoxy]phenyl]-3-methyl-6-methoxy-4(3H)-quinazolinone ([+/-]HX-CH 44) as a selective beta 1-adrenoceptor ligand for PET, NUCL MED BI, 26(1), 1999, pp. 105-109
Authors:
Dolci, L
Dolle, F
Valette, H
Vaufrey, F
Fuseau, C
Bottlaender, M
Crouzel, C
Citation: L. Dolci et al., Synthesis of a fluorine-18 labeled derivative of epibatidine for in vivo nicotinic acetylcholine receptor PET imaging, BIO MED CH, 7(3), 1999, pp. 467-479
Authors:
Valette, H
Bottlaender, M
Dolle, F
Guenther, I
Fuseau, C
Coulon, C
Ottaviani, M
Crouzel, C
Citation: H. Valette et al., Imaging central nicotinic acetylcholine receptors in baboons with [F-18]fluoro-A-85380, J NUCL MED, 40(8), 1999, pp. 1374-1380
Authors:
Dolle, F
Dolci, L
Valette, H
Hinnen, F
Vaufrey, F
Guenther, I
Fuseau, C
Coulon, C
Bottlaender, M
Crouzel, C
Citation: F. Dolle et al., Synthesis and nicotinic acetylcholine receptor in vivo binding properties of 2-fluoro-3-[2(S)-2-azetidinylmethoxy]pyridine: A new positron emission tomography ligand for nicotinic receptors, J MED CHEM, 42(12), 1999, pp. 2251-2259
Characterization of the nicotinic ligand 2-[F-18]fluoro-3-[2(S)-2-azetidinylmethoxy]pyridine in vivo
Authors:
Valette, H
Bottlaender, M
Dolle, F
Guenther, I
Coulon, C
Hinnen, F
Fuseau, C
Ottaviani, M
Crouzel, C
Citation: H. Valette et al., Characterization of the nicotinic ligand 2-[F-18]fluoro-3-[2(S)-2-azetidinylmethoxy]pyridine in vivo, LIFE SCI, 64(5), 1998, pp. PL93-PL97
Risultati:
1-12
|